Athyrium Capital Management, LP 13F Holdings · last filed Q3 2024
Athyrium Capital Management, LP reported 2 securities worth $8.69M in its SEC 13F filing for Q3 2024 (period ended 2024-09-30). Top holdings: BIOR (63.12%), PBYI (36.88%), CHRS (0.00%). Among its top 25 positions this quarter: 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BIOR | Biora Therapeutics Inc. | $5.5M | 63.12% | 10.9M | Hold |
| 2 | PBYI | PUMA BIOTECHNOLOGY INC | $3.2M | 36.88% | 1.3M | Hold |
| 3 | CHRS | COHERUS BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2024-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR